Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
Indian generic drugs generated a revenue of around 21 billion U.S. dollars in the prescribed drug market in 2015. This was expected to go up to approximately 28 billion dollars by 2020, indicating a strong competence and growth in this drug segment. Overall, generic drugs had about 70 percent of market share in terms of revenue for India's pharmaceutical sector in 2019.
Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Basic Statistic Spending on R&D from pharmaceutical industry in Canada 2004-2022
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Premium Statistic Members of EFPIA's pharmaceutical R&D spending 1990-2022
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
About the region
10
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic HAL sales turnover FY 2014-2023
- Premium Statistic HAL net profit FY 2014-2023
- Premium Statistic KAPL production value FY 2014-2022
- Premium Statistic KAPL sales value FY 2014-2022
- Premium Statistic BCPL's production value FY 2014-2023
- Premium Statistic BCPL net profit FY 2014-2023
- Premium Statistic RDPL total turnover FY 2017-2019
- Premium Statistic Distribution of the functional beverage market in India 2018 by product type
- Premium Statistic Distribution of the dietary supplements market in India 2018 by product type
Selected statistics
9
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Premium Statistic Total worldwide prescription drug revenue - projection 2020-2028
- Premium Statistic Price increase select geriatric drugs in the U.S. in 2020
- Premium Statistic Top pharmaceutical products in Canada by sales 2022
- Basic Statistic Pharmacy market sales' parallel import share - European countries 2021
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2023
- Premium Statistic Pharma market value in Colombia 2008-2021
- Premium Statistic Pharma market value in Argentina 2008-2021
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Mexico: pharma industry market value 2008-2016
Related statistics
10
- Premium Statistic BCPL turnover 2014-Q3 2018
- Premium Statistic Lupin's net sales FY 2015-2023
- Premium Statistic Hindustan Antibiotics production value of FY 2014-2023
- Premium Statistic Distribution of pharmaceutical market revenue in India 2020, by sub segment
- Basic Statistic Share of hypertension market India FY 2020, by drug class
- Basic Statistic Value of hyperlipidemia market India FY 2020, by drug class
- Basic Statistic Value of anti-thrombotic market India FY 2020, by drug class
- Basic Statistic Market value of leading molecules in the cardiac segment India FY 2020
- Basic Statistic Market value of leading fastest growing molecules in cardiac segment India FY 2020
- Basic Statistic Market value of leading brand in the cardiac segment India FY 2020
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
India Brand Equity Foundation. (June 25, 2019). Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars)." Chart. June 25, 2019. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. (2019). Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of Generic Drugs in The Prescribed Drug Market in India from 2008 to 2015 with a Forecast for 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 25 Jun 2019, https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation, Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/ (last visited May 21, 2024)
Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) [Graph], India Brand Equity Foundation, June 25, 2019. [Online]. Available: https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/